1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
MHC-peptide tetramer technology is reshaping the global immunology landscape by enabling precise, high-throughput identification of antigen-specific T cell populations, driving advances in clinical diagnostics and translational research.
Market Snapshot: MHC-Peptide Tetramer Market Growth
The MHC-peptide tetramer market is experiencing significant expansion, propelled by technological innovations in cytometry and sequencing, increased adoption across immunotherapy and vaccine development, and growing demand in both academic and clinical sectors. As integration between detection platforms and computational analytics accelerates, stakeholders are allocating resources to leverage advanced immune profiling tools for enhanced research outcomes and patient care.
Scope & Segmentation
- Product Types: Class I (HLA-A, HLA-B, HLA-C), Class II (HLA-DP, HLA-DQ, HLA-DR)
- Technology Modalities: Fluorescence (Allophycocyanin, FITC, Phycoerythrin), Mass Cytometry (Lanthanide tags), Next Generation Sequencing (Bulk and Single Cell Sequencing)
- Applications: Clinical Diagnostics (disease diagnosis in autoimmune disorders and cancer, immunotherapy and transplantation monitoring), Basic Research (cancer immunology, infectious disease studies), Translational Research (cell therapy, vaccine development)
- End Users: Academic institutes (research centers, universities), Contract research organizations (Global, Regional), Pharma and Biotech companies (Large Pharma, Small Biotech)
- Regions: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, and more), Asia-Pacific (China, India, Japan, Australia, South Korea, and others)
- Key Companies: Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Miltenyi Biotec GmbH, Beckman Coulter, Inc., MBL International Corporation, BioLegend, Inc., ProImmune Ltd., JPT Peptide Technologies GmbH
MHC-Peptide Tetramer Technology: Key Takeaways
- Next-generation high-parameter cytometry and sequencing are transforming immunomonitoring workflows, improving resolution and assay throughput in both research and clinical settings.
- Enhanced tetramer reagent designs including optimized peptide exchange and backbone stability are enabling greater assay sensitivity and reducing background interference.
- Digital data management, powered by machine learning, is driving faster, clearer insights through streamlined immune profiling and interpretation.
- Regional nuances are evident: Americas display high adoption rates due to strong research funding; EMEA benefits from regulatory harmonization and local manufacturing, while Asia-Pacific is fueled by R&D investment and industry partnerships.
- Strategic collaborations between reagent providers, contract research organizations, and biotech companies are accelerating market evolution and fostering robust, application-specific panel development.
Tariff Impact on the MHC-Peptide Tetramer Market
The implementation of revised United States tariffs in 2025 has affected supply chain continuity and escalated procurement costs for reagents and lab instruments. This is prompting organizations to reevaluate supplier contracts, pursue regional manufacturing, and invest in modular kits as a buffer against import duties. Despite these pressures, industry players continue to prioritize innovation and operational efficiency, adopting automation and digital procurement to maintain competitiveness.
Methodology & Data Sources
This report utilizes a multi-source research methodology, combining primary interviews with immunology experts, assay developers, and procurement leaders alongside secondary analysis of peer-reviewed literature, clinical registries, and regulatory documents. Rigorous triangulation and expert workshops validate key findings for reliability and depth.
Why This Report Matters
- Delivers actionable insights for supply chain optimization, product roadmap planning, and regulatory alignment in a complex, quickly evolving field.
- Helps guide strategic decisions for both established market leaders and emerging innovators by detailing segment-specific drivers and regional opportunities.
- Supports resource prioritization for organizations navigating uncertainty around tariffs, research investment, and partnership formation.
Conclusion
The MHC-peptide tetramer market is defined by technological progress, responsive supply chain strategies, and evolving collaborative models. Decision-makers equipped with this insight are positioned to maximize opportunities and advance impactful immunology solutions across global healthcare and research environments.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of multimer flow cytometry assays for high throughput T cell analysis
5.2. Growing demand for personalized immuno monitoring assays in cancer immunotherapy research
5.3. Expansion of peptide-MHC tetramer applications in neoantigen discovery and vaccine development
5.4. Integration of fluorescent barcoding technology to improve multiplexed T cell specificity profiling
5.5. Rising investments in reagent standardization for enhanced reproducibility in tetramer assays
5.6. Emergence of AI-driven epitope prediction tools accelerating tetramer design and screening processes
5.7. Strategic collaborations between biotech companies and academic institutions to advance tetramer platforms
5.8. Introduction of microfluidics-based platforms for single-cell tetramer screening and analysis
5.2. Growing demand for personalized immuno monitoring assays in cancer immunotherapy research
5.3. Expansion of peptide-MHC tetramer applications in neoantigen discovery and vaccine development
5.4. Integration of fluorescent barcoding technology to improve multiplexed T cell specificity profiling
5.5. Rising investments in reagent standardization for enhanced reproducibility in tetramer assays
5.6. Emergence of AI-driven epitope prediction tools accelerating tetramer design and screening processes
5.7. Strategic collaborations between biotech companies and academic institutions to advance tetramer platforms
5.8. Introduction of microfluidics-based platforms for single-cell tetramer screening and analysis
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. MHC-Peptide Tetramer Market, by Product Type
8.1. Introduction
8.2. Class I
8.2.1. Hla a
8.2.2. Hla B
8.2.3. Hla C
8.3. Class Ii
8.3.1. Hla Dp
8.3.2. Hla Dq
8.3.3. Hla Dr
8.2. Class I
8.2.1. Hla a
8.2.2. Hla B
8.2.3. Hla C
8.3. Class Ii
8.3.1. Hla Dp
8.3.2. Hla Dq
8.3.3. Hla Dr
9. MHC-Peptide Tetramer Market, by Technology
9.1. Introduction
9.2. Fluorescence
9.2.1. Allophycocyanin
9.2.2. Fitc
9.2.3. Phycoerythrin
9.3. Mass Cytometry
9.3.1. Lanthanide Tags
9.4. Next Generation Sequencing
9.4.1. Bulk Sequencing
9.4.2. Single Cell Sequencing
9.2. Fluorescence
9.2.1. Allophycocyanin
9.2.2. Fitc
9.2.3. Phycoerythrin
9.3. Mass Cytometry
9.3.1. Lanthanide Tags
9.4. Next Generation Sequencing
9.4.1. Bulk Sequencing
9.4.2. Single Cell Sequencing
10. MHC-Peptide Tetramer Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.2.1. Disease Diagnosis
10.2.1.1. Autoimmune Disorders
10.2.1.2. Cancer
10.2.2. Therapy Monitoring
10.2.2.1. Immunotherapy
10.2.2.2. Transplantation
10.3. Research
10.3.1. Basic Research
10.3.1.1. Cancer Immunology
10.3.1.2. Infectious Disease
10.3.2. Translational Research
10.3.2.1. Cell Therapy
10.3.2.2. Vaccine Development
10.2. Clinical Diagnostics
10.2.1. Disease Diagnosis
10.2.1.1. Autoimmune Disorders
10.2.1.2. Cancer
10.2.2. Therapy Monitoring
10.2.2.1. Immunotherapy
10.2.2.2. Transplantation
10.3. Research
10.3.1. Basic Research
10.3.1.1. Cancer Immunology
10.3.1.2. Infectious Disease
10.3.2. Translational Research
10.3.2.1. Cell Therapy
10.3.2.2. Vaccine Development
11. MHC-Peptide Tetramer Market, by End User
11.1. Introduction
11.2. Academic Institutes
11.2.1. Research Centers
11.2.2. Universities
11.3. Contract Research Organizations
11.3.1. Global CROS
11.3.2. Regional CROS
11.4. Pharma Biotech Companies
11.4.1. Large Pharma
11.4.2. Small Biotech
11.2. Academic Institutes
11.2.1. Research Centers
11.2.2. Universities
11.3. Contract Research Organizations
11.3.1. Global CROS
11.3.2. Regional CROS
11.4. Pharma Biotech Companies
11.4.1. Large Pharma
11.4.2. Small Biotech
12. Americas MHC-Peptide Tetramer Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa MHC-Peptide Tetramer Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific MHC-Peptide Tetramer Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Becton, Dickinson and Company
15.3.3. Miltenyi Biotec GmbH
15.3.4. Beckman Coulter, Inc.
15.3.5. MBL International Corporation
15.3.6. BioLegend, Inc.
15.3.7. ProImmune Ltd.
15.3.8. JPT Peptide Technologies GmbH
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Becton, Dickinson and Company
15.3.3. Miltenyi Biotec GmbH
15.3.4. Beckman Coulter, Inc.
15.3.5. MBL International Corporation
15.3.6. BioLegend, Inc.
15.3.7. ProImmune Ltd.
15.3.8. JPT Peptide Technologies GmbH
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. MHC-PEPTIDE TETRAMER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MHC-PEPTIDE TETRAMER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MHC-PEPTIDE TETRAMER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MHC-PEPTIDE TETRAMER MARKET: RESEARCHAI
FIGURE 24. MHC-PEPTIDE TETRAMER MARKET: RESEARCHSTATISTICS
FIGURE 25. MHC-PEPTIDE TETRAMER MARKET: RESEARCHCONTACTS
FIGURE 26. MHC-PEPTIDE TETRAMER MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. MHC-PEPTIDE TETRAMER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. MHC-PEPTIDE TETRAMER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. MHC-PEPTIDE TETRAMER MARKET: RESEARCHAI
FIGURE 24. MHC-PEPTIDE TETRAMER MARKET: RESEARCHSTATISTICS
FIGURE 25. MHC-PEPTIDE TETRAMER MARKET: RESEARCHCONTACTS
FIGURE 26. MHC-PEPTIDE TETRAMER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MHC-PEPTIDE TETRAMER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA A, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA A, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA B, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA B, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA C, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA C, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DP, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DP, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DQ, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DQ, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ALLOPHYCOCYANIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ALLOPHYCOCYANIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FITC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FITC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHYCOERYTHRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHYCOERYTHRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LANTHANIDE TAGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LANTHANIDE TAGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BULK SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BULK SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SINGLE CELL SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SINGLE CELL SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY GLOBAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY GLOBAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGIONAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGIONAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 204. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 205. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 206. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 207. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 210. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 211. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 212. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 213. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 220. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 221. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 222. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 223. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 224. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 225. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 226. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 227. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 228. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 229. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 232. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 233. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 258. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 259. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 260. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 261. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 262. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 263. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 265. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH,
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA A, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA A, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA B, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA B, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA C, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA C, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DP, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DP, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DQ, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DQ, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DR, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY HLA DR, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ALLOPHYCOCYANIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ALLOPHYCOCYANIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FITC, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FITC, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHYCOERYTHRIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHYCOERYTHRIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LANTHANIDE TAGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LANTHANIDE TAGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BULK SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BULK SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SINGLE CELL SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SINGLE CELL SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSPLANTATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CANCER IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CELL THERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CELL THERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY UNIVERSITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY GLOBAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY GLOBAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGIONAL CROS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY REGIONAL CROS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY LARGE PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY SMALL BIOTECH, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS MHC-PEPTIDE TETRAMER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES MHC-PEPTIDE TETRAMER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 201. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 202. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 203. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 204. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 205. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 206. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 207. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 210. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 211. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 212. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 213. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 214. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 215. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 216. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 217. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 218. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 219. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 220. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 221. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 222. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 223. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 224. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 225. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 226. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 227. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 228. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 229. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 232. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 233. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 234. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 235. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 237. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 240. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 241. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 242. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 243. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 246. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 247. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 248. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 249. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 250. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 251. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 252. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 253. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 254. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 255. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 258. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 259. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 260. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 261. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 262. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 263. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 264. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 265. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 266. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 267. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 268. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 269. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 270. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 271. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY BASIC RESEARCH, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY TRANSLATIONAL RESEARCH, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY ACADEMIC INSTITUTES, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL MHC-PEPTIDE TETRAMER MARKET SIZE, BY PHARMA BIOTECH COMPANIES, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS I, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLASS II, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY FLUORESCENCE, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY MASS CYTOMETRY, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY DISEASE DIAGNOSIS, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY THERAPY MONITORING, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA MHC-PEPTIDE TETRAMER MARKET SIZE, BY RESEARCH,
Samples
LOADING...
Companies Mentioned
The companies profiled in this MHC-Peptide Tetramer market report include:- Thermo Fisher Scientific Inc.
- Becton, Dickinson and Company
- Miltenyi Biotec GmbH
- Beckman Coulter, Inc.
- MBL International Corporation
- BioLegend, Inc.
- ProImmune Ltd.
- JPT Peptide Technologies GmbH
